MA42946A - Sels et formes solides d'un antibiotique de type monobactame - Google Patents
Sels et formes solides d'un antibiotique de type monobactameInfo
- Publication number
- MA42946A MA42946A MA42946A MA42946A MA42946A MA 42946 A MA42946 A MA 42946A MA 42946 A MA42946 A MA 42946A MA 42946 A MA42946 A MA 42946A MA 42946 A MA42946 A MA 42946A
- Authority
- MA
- Morocco
- Prior art keywords
- salts
- solid forms
- monobactam antibiotic
- oxo
- amino
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 2
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 title 1
- 229960003644 aztreonam Drugs 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- FWTGYTRQUBRVDW-NRABZWKMSA-N NC=1SC=C(N1)/C(/C(N[C@@H]1C(N([C@@H]1CN1C(OCC1)=O)S(=O)(=O)O)=O)=O)=N/OC1(CC1)C(=O)O Chemical compound NC=1SC=C(N1)/C(/C(N[C@@H]1C(N([C@@H]1CN1C(OCC1)=O)S(=O)(=O)O)=O)=O)=N/OC1(CC1)C(=O)O FWTGYTRQUBRVDW-NRABZWKMSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La fourniture de nouvelles formes solides, des sels et des polymorphes d'acide 1-(((z)-(1-(2-aminothiazol-4-yl)2-oxo-2-(((3s,4r)-2-oxo-4-((2-oxooxazolidine-3-yl)méthyl)-1-sulfoazetidin-3-yl)amino)éthylidène)amino)oxy)-cyclopropanecarboxylique (désigné ici en tant que composé x), des compositions pharmaceutiques les contenant et des procédés pour leur fabrication et leur utilisation en thérapie.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222430P | 2015-09-23 | 2015-09-23 | |
| PCT/CN2016/099482 WO2017050218A1 (fr) | 2015-09-23 | 2016-09-20 | Sels et formes solides d'antibiotique monobactame |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA42946A true MA42946A (fr) | 2018-08-01 |
| MA42946B1 MA42946B1 (fr) | 2020-10-28 |
Family
ID=58385723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42946A MA42946B1 (fr) | 2015-09-23 | 2016-09-20 | Sels et formes solides d'un antibiotique de type monobactame |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10919887B2 (fr) |
| EP (1) | EP3353175B1 (fr) |
| JP (1) | JP6837480B2 (fr) |
| KR (1) | KR102749337B1 (fr) |
| CN (1) | CN108137573B (fr) |
| AU (1) | AU2016327264B2 (fr) |
| CA (1) | CA2999794C (fr) |
| CL (2) | CL2018000745A1 (fr) |
| CY (1) | CY1123509T1 (fr) |
| DK (1) | DK3353175T3 (fr) |
| EA (2) | EA037569B1 (fr) |
| ES (1) | ES2817537T3 (fr) |
| HR (1) | HRP20201423T1 (fr) |
| HU (1) | HUE050849T2 (fr) |
| IL (1) | IL258254B (fr) |
| LT (1) | LT3353175T (fr) |
| MA (1) | MA42946B1 (fr) |
| MX (1) | MX377532B (fr) |
| PH (1) | PH12018500653B1 (fr) |
| PL (1) | PL3353175T3 (fr) |
| PT (1) | PT3353175T (fr) |
| RS (1) | RS60805B1 (fr) |
| RU (1) | RU2754180C2 (fr) |
| SI (1) | SI3353175T1 (fr) |
| SM (1) | SMT202000480T1 (fr) |
| WO (1) | WO2017050218A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019026004A2 (fr) * | 2017-08-02 | 2019-02-07 | Novartis Ag | Processus chimique de préparation d'antibiotique monobactame et de ses intermédiaires |
| CN111032792A (zh) * | 2017-08-16 | 2020-04-17 | 株式会社Lg化学 | 包含zif类粉末的白色颜料、聚合物树脂膜和使用白色颜料改变介质的颜色的方法 |
| US20200360349A1 (en) * | 2017-11-10 | 2020-11-19 | Novartis Ag | Administration of monobactam for the treatment of urinary tract infection |
| EP3747883A4 (fr) * | 2018-01-29 | 2020-12-16 | Medshine Discovery Inc. | Composé b-lactame monocyclique pour traiter une infection bactérienne |
| CN113227088B (zh) * | 2018-12-18 | 2022-05-31 | 南京明德新药研发有限公司 | 单环β-内酰胺化合物在制药中的应用 |
| CN114787158B (zh) * | 2019-11-22 | 2023-10-24 | 苏州二叶制药有限公司 | 磺酰脲环取代的单环β-内酰胺类抗生素 |
| CN114828850B (zh) | 2019-12-19 | 2024-08-13 | 深圳嘉科生物科技有限公司 | 化合物在制药中的应用 |
| CN113754651B (zh) | 2020-06-02 | 2023-04-18 | 中国医学科学院医药生物技术研究所 | 一种β-内酰胺化合物、其用途及其制备方法 |
| EP4007759A4 (fr) | 2020-08-06 | 2024-04-10 | Ningxia Academy of Agriculture and Forestry Sciences | Composés de bêta-lactame, leur préparation et leur utilisation comme agents antibactériens |
| WO2022185240A1 (fr) | 2021-03-04 | 2022-09-09 | Bp Asset Vi, Inc. | Formulation d'un antibiotique monobactame |
| WO2022185241A1 (fr) | 2021-03-04 | 2022-09-09 | Bp Asset Vi, Inc. | Procédé de fabrication d'un antibiotique monobactame |
| CN115304594B (zh) * | 2022-10-12 | 2023-02-14 | 苏州二叶制药有限公司 | 磺酰脲环取代的化合物的盐型及其晶型 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ196202A (en) | 1980-02-07 | 1984-07-31 | Squibb & Sons Inc | Beta-lactam antibiotics (of azetidine-sulphonic acid type) |
| US4775670A (en) | 1980-09-29 | 1988-10-04 | E. R. Squibb & Sons, Inc. | 2-oxo-1-azetidinesulfonic acid salts |
| EP0048953B1 (fr) | 1980-09-29 | 1988-03-09 | E.R. Squibb & Sons, Inc. | Antibiotiques de bêta-lactame |
| WO1982001873A1 (fr) | 1980-12-05 | 1982-06-10 | Takeda Chemical Industries Ltd | Derives 1-sulfo-2-oxoazetidine et leur procede de preparation |
| US4782147A (en) | 1980-12-05 | 1988-11-01 | Takeda Chemical Industries, Ltd. | 1-sulfo-2-oxoazetidine derivatives and their production |
| CA1262128A (fr) | 1981-08-27 | 1989-10-03 | Christian N. Hubschwerlen | .beta.-lactams |
| IL67451A (en) | 1981-12-25 | 1987-10-20 | Takeda Chemical Industries Ltd | 4-cyano-2-azetidinones and production thereof and process for the preparation of 4-carbamoyl-2-azetidinones using them |
| AU564150B2 (en) * | 1982-04-30 | 1987-08-06 | Takeda Chemical Industries Ltd. | 1-sulfo-2-azetidinone derivatives |
| KR900005112B1 (ko) | 1982-05-31 | 1990-07-19 | 반유세이야꾸 가부시끼가이샤 | 2-옥소-1-아제티딘술폰산 유도체의 제조방법 |
| EP0096297B1 (fr) | 1982-06-03 | 1988-06-15 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Procédé de préparation de dérivés de 1-sulfo-2-oxoazétidine |
| JPS6153282A (ja) | 1984-08-22 | 1986-03-17 | Banyu Pharmaceut Co Ltd | 単環β−ラクタム誘導体 |
| JPS6153283A (ja) | 1984-08-24 | 1986-03-17 | Banyu Pharmaceut Co Ltd | ２−オキソ−１−アゼチジンスルホン酸誘導体 |
| US4610824A (en) | 1984-10-09 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Hydrazide derivatives of monocyclic beta-lactam antibiotics |
| US5112968A (en) | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
| DK2960244T3 (en) | 2008-10-31 | 2016-11-28 | Shionogi & Co | Cephalosporin antibiotic with catechol |
| SG171781A1 (en) * | 2008-12-19 | 2011-07-28 | Pfizer | Monocarbams |
| CA2815821C (fr) * | 2010-11-29 | 2015-07-07 | Pfizer Inc. | Monobactames utiles dans le traitement des infections bacteriennes |
| UY34585A (es) * | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
| CN103044416A (zh) | 2012-12-17 | 2013-04-17 | 浙江华方药业有限责任公司 | 一种卡芦莫南钠的合成方法 |
| WO2015103583A1 (fr) | 2014-01-06 | 2015-07-09 | President And Fellows Of Harvard College | Monobactames et procédés de synthèse et d'utilisation de ces derniers |
| PL3122745T3 (pl) * | 2014-03-24 | 2019-08-30 | Novartis Ag | Monobaktamowe związki organiczne do leczenia zakażeń bakteryjnych |
-
2016
- 2016-09-20 SM SM20200480T patent/SMT202000480T1/it unknown
- 2016-09-20 MA MA42946A patent/MA42946B1/fr unknown
- 2016-09-20 DK DK16848099.4T patent/DK3353175T3/da active
- 2016-09-20 HR HRP20201423TT patent/HRP20201423T1/hr unknown
- 2016-09-20 RU RU2018114480A patent/RU2754180C2/ru active
- 2016-09-20 JP JP2018515607A patent/JP6837480B2/ja active Active
- 2016-09-20 AU AU2016327264A patent/AU2016327264B2/en active Active
- 2016-09-20 PT PT168480994T patent/PT3353175T/pt unknown
- 2016-09-20 MX MX2018003592A patent/MX377532B/es active IP Right Grant
- 2016-09-20 WO PCT/CN2016/099482 patent/WO2017050218A1/fr not_active Ceased
- 2016-09-20 RS RS20201038A patent/RS60805B1/sr unknown
- 2016-09-20 CA CA2999794A patent/CA2999794C/fr active Active
- 2016-09-20 EA EA201890771A patent/EA037569B1/ru not_active IP Right Cessation
- 2016-09-20 EP EP16848099.4A patent/EP3353175B1/fr active Active
- 2016-09-20 SI SI201630906T patent/SI3353175T1/sl unknown
- 2016-09-20 US US15/762,724 patent/US10919887B2/en active Active
- 2016-09-20 PH PH1/2018/500653A patent/PH12018500653B1/en unknown
- 2016-09-20 PL PL16848099.4T patent/PL3353175T3/pl unknown
- 2016-09-20 EA EA202092620A patent/EA202092620A1/ru unknown
- 2016-09-20 HU HUE16848099A patent/HUE050849T2/hu unknown
- 2016-09-20 LT LTEP16848099.4T patent/LT3353175T/lt unknown
- 2016-09-20 KR KR1020187011354A patent/KR102749337B1/ko active Active
- 2016-09-20 CN CN201680055680.4A patent/CN108137573B/zh active Active
- 2016-09-20 ES ES16848099T patent/ES2817537T3/es active Active
-
2018
- 2018-03-20 IL IL258254A patent/IL258254B/en active IP Right Grant
- 2018-03-21 CL CL2018000745A patent/CL2018000745A1/es unknown
-
2019
- 2019-11-20 CL CL2019003324A patent/CL2019003324A1/es unknown
-
2020
- 2020-09-07 CY CY20201100840T patent/CY1123509T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA42946A (fr) | Sels et formes solides d'un antibiotique de type monobactame | |
| CL2018001510A1 (es) | Composición farmacéutica que comprende un potente inhibidor de urat1 | |
| PE20141824A1 (es) | Compuestos terapeuticamente activos y sus metodos de uso | |
| EP2727605A4 (fr) | Analogue d'exendine-4 pégylé par du polyéthylène glycol ou un dérivé de celui-ci, son procédé de préparation et composition pharmaceutique pour prévenir ou traiter le diabète, le contenant en tant que principe actif | |
| BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| MX2021009806A (es) | Ésteres de ácidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y métodos para usar los mismos. | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| MX2016000307A (es) | Farmaco para el tratamiento de la esteatosis hepatica no alcoholica. | |
| PE20180411A1 (es) | Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina | |
| PE20141148A1 (es) | Mesilato de n-[5-(aminosulfonil)-4 metil-1-3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato | |
| ZA201802312B (en) | A group of compounds used for the treatment or prevention of hyperuricemia or gout | |
| EP3498264A4 (fr) | Préparation pharmaceutique pour administration orale à vitesse de dissolution contrôlée, la préparation comprenant des pastilles à libération prolongée contenant du chlorhydrate de tamsulosine | |
| MX374628B (es) | Formulacion que comprende un agente hipolipidemico. | |
| MA38854B1 (fr) | Dérivés amides utilisés en tant qu'antagonistes des récepteurs de l'acide lysophosphatidique | |
| BR112022006608A2 (pt) | Inibidores orais do fator d do complemento | |
| BR112013020456A2 (pt) | nova composição antifúngica | |
| BR122020011180B8 (pt) | formulações injetáveis de compostos de tetraciclina | |
| CL2008001990A1 (es) | Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer. | |
| MA44079B1 (fr) | Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine | |
| CL2016002318A1 (es) | Composición farmacéutica en forma de solución que comprende un portador líquido que comprende agua y entre 20% y 95% de uno o mas alcoholes y citrato de sildenafil disuelto en dicho portador líquido a una concentración de entre 7 y 125 mg/ml; métodos para obtenerla; forma de dosificación oral; forma de dosificación bucal; kits. | |
| HRP20200161T1 (hr) | (r)-3-((3s,4s)-3-fluoro-4-(4-hidroksifenil)piperidin-1-il)-1-(4-metilbenzil)pirolidin-2-on i njegovi prolijekovi za liječenje psihijatrijskih poremećaja | |
| MX2017010666A (es) | Acido (2r,4r)-5-(5'-cloro-2'-fluorobifenil-4-il)-2-hidroxi-4-[(5-m etiloxazol-2-carbonil)amino]pentanoico. | |
| MA39229A1 (fr) | Pyrrolidines, térahydrofuranes et cyclopentanes substitués utiles en tant qu'antagonistes des récepteurs des orexines | |
| EP3533450A4 (fr) | Composition pharmaceutique destinée à prévenir ou à traiter une lésion d'ischémie-reperfusion, contenant de l'acide biliaire | |
| AU2018311521A8 (en) | Process for preparing 1 -(((Z)-(1 -(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-y l)methyl)-1 -sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid |